Europe Bioprocess Technology Market Outlook, 2029

The Europe Bioprocess Technology Market is experiencing significanr growth , driven by prevalence of chronic diseases.

According to publisher, Here is the Europe Bioprocess Technology Market Report Market Insights The European bioprocess technology market is experiencing significant growth, driven by several factors: Rising demand for biopharmaceuticals: An aging population and increasing prevalence of chronic diseases like cancer are fueling demand for advanced therapies, such as monoclonal antibodies and vaccines, produced through bioprocessing. Focus on R&D: Biopharmaceutical companies are investing heavily in research and development to bring innovative drugs to market faster. Bioprocess technologies play a crucial role in optimizing production processes and improving efficiency. Shift towards single-use systems: Single-use bioprocessing systems offer advantages like reduced contamination risk, faster turnaround times, and lower operational costs. This trend is expected to continue, propelling market growth. The market size is estimated to be around USD 12.3 billion in 2023 and is projected to reach USD 26.6 billion by 2028, with a Compound Annual Growth Rate (CAGR) of 16.7%.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Market Dynamics Drivers: Growing adoption of biosimilars: Biosimilars are similar versions of existing biological drugs and offer a cost-effective alternative. Increased biosimilar production will drive the need for advanced bioprocessing technologies. Stringent regulatory requirements: Stringent regulations governing biopharmaceutical manufacturing necessitate advanced technologies for process control and data integrity. Restraints: High initial investment costs: Bioprocessing equipment can be expensive, posing a challenge for smaller companies entering the market. Stringent regulatory hurdles: The complex regulatory environment for biopharmaceutical manufacturing can slow down the adoption of new technologies. Market Segments By Product: Instruments (Bioreactors, fermenters, chromatography systems) Consumables (Filters, media, biocontainers) Accessories (Sensors, probes, tubing) By Application: Recombinant proteins (e.g., insulin) Monoclonal antibodies (e.g., for cancer treatment) Antibiotics Vaccines

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

By End-User: Biopharmaceutical companies Contract Manufacturing Organizations (CMOs) Academic research institutes Other end-users (e.g., food & beverage industry) Regional Analysis Germany is a leading market in Europe, accounting for over 27% of the demand in 2020 due to a strong presence of biopharmaceutical companies and a focus on innovative bio-based medicines. Other major markets include the United Kingdom, France, Switzerland, and Italy. Eastern Europe is expected to witness significant growth due to rising investments in biopharmaceutical infrastructure. Key Developments Continuous bioprocessing: This emerging trend involves continuous production of biopharmaceuticals rather than batch processing. It offers advantages like increased efficiency, reduced costs, and smaller production footprints. Companies are investing in developing and deploying continuous bioprocessing technologies. Digitalization: The adoption of digital technologies like artificial intelligence and machine learning is transforming bioprocessing. These technologies can be used for process optimization, predictive maintenance, and data analysis, leading to improved efficiency and quality control.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Competitive Landscape The European bioprocess technology market is a competitive landscape with a mix of established players and emerging companies. Some of the key players include: Thermo Fisher Scientific Merck KGaA Danaher Corporation (Pall Corporation) Sartorius Stedim Biotech GE Healthcare These companies are focusing on innovation, strategic partnerships, and geographic expansion to maintain their market share. Mergers and acquisitions are also expected to shape the competitive landscape in the coming years. Conclusion The European bioprocess technology market is poised for significant growth due to rising demand for biopharmaceuticals, increasing R&D investments, and technological advancements. Stringent regulations and high initial costs are some challenges, but the overall outlook for the market remains positive. Key players are focusing on innovation and strategic partnerships to capitalize on the growth opportunities.

Table of Contents

  • 1 Introduction 7
  • 1.1 Industry Definition and Research Scope 7
  • 1.1.1 Industry Definition 7
  • 1.1.2 Research Scope 8
  • 1.2 Research Methodology 11
  • 1.2.1 Overview of Market Research Methodology 11
  • 1.2.2 Market Assumption 12
  • 1.2.3 Secondary Data 12
  • 1.2.4 Primary Data 12
  • 1.2.5 Data Filtration and Model Design 13
  • 1.2.6 Market Size/Share Estimation 14
  • 1.2.7 Research Limitations 15
  • 1.3 Executive Summary 16
  • 2 Market Overview and Dynamics 19
  • 2.1 Market Size and Forecast 19
  • 2.1.1 Impact of COVID-19 on World Economy 20
  • 2.1.2 Impact of COVID-19 on the Market 24
  • 2.1.3 Impact of Russia-Ukraine Conflict 26
  • 2.1.4 Impact of Israel-Palestine War 28
  • 2.2 Major Growth Drivers 29
  • 2.3 Market Restraints and Challenges 34
  • 2.4 Emerging Opportunities and Market Trends 37
  • 2.5 Porter’s Fiver Forces Analysis 41
  • 3 Segmentation of Europe Market by Product 45
  • 3.1 Market Overview by Product 45
  • 3.2 Instruments 47
  • 3.2.1 Bioprocess Analyzers 49
  • 3.2.2 Osmometers 50
  • 3.2.3 Bioreactors 51
  • 3.2.4 Incubators 52
  • 3.2.5 Other Instruments 53
  • 3.3 Consumables and Accessories 54
  • 3.3.1 Culture Media 56
  • 3.3.2 Reagents 57
  • 3.3.3 Other Consumables and Accessories 58
  • 4 Segmentation of Europe Market by Process 59
  • 4.1 Market Overview by Process 59
  • 4.2 Upstream Bioprocessing 61
  • 4.3 Downstream Bioprocessing 62
  • 5 Segmentation of Europe Market by Procedure 63
  • 5.1 Market Overview by Procedure 63
  • 5.2 Cell Culture 65
  • 5.3 Cell Expansion 66
  • 5.4 Flow Cytometry 67
  • 5.5 Cell Line Development 68
  • 5.6 Cell Counting 69
  • 5.7 Biologics Safety Testing 70
  • 5.8 Tangential Flow Filtration (TFF) 71
  • 5.9 Other Procedures 72
  • 6 Segmentation of Europe Market by Application 73
  • 6.1 Market Overview by Application 73
  • 6.2 Recombinant Proteins 75
  • 6.3 Antibiotics 76
  • 6.4 Biosimilars 77
  • 6.5 Monoclonal Antibodies (mAbs) 78
  • 6.6 Other Applications 79
  • 7 Segmentation of Europe Market by End User 80
  • 7.1 Market Overview by End User 80
  • 7.2 Biopharmaceutical Companies 82
  • 7.3 Contract Manufacturing Organizations (CMOs) 83
  • 7.4 Academic Research Institutes 84
  • 7.5 Contract Research Organizations (CROs) 85
  • 7.6 Food & Feed Industry 86
  • 7.7 Other End Users 87
  • 8 European Market 2023-2033 by Country 88
  • 8.1 Overview of European Market 88
  • 8.2 Germany 91
  • 8.3 U.K. 93
  • 8.4 France 95
  • 8.5 Spain 97
  • 8.6 Italy 99
  • 8.7 Netherlands 101
  • 8.8 Rest of European Market 103
  • 9 Competitive Landscape 105
  • 9.1 Overview of Key Vendors 105
  • 9.2 New Product Launch, Partnership, Investment, and M&A 109
  • 9.3 Company Profiles 110
  • Advanced Instruments LLC 110
  • Agilent Technologies, Inc. 112
  • Becton Dickinson and Company 113
  • Bio-rad Laboratories Inc. 114
  • Boehringer Ingelheim International GmbH 115
  • Catalent Inc. 116
  • Charles River Laboratories 117
  • Corning Inc. 118
  • Danaher Corporation 119
  • Elitechgroup Inc. (gonotec Gmbh) 120
  • Eppendorf Se 121
  • F. Hoffmann-la Roche Ltd. 122
  • Fujifilm Healthcare Americas Corporation 123
  • GE Healthcare (General Electric Company) 124
  • Getinge Ab 125
  • Koninklijke Philips N.V. 126
  • Lonza Group Ag 127
  • Merck Kgaa 128
  • Repligen Corp. 129
  • Sartorius Group 130
  • STADA Arzneimittel AG 131
  • Thermo Fisher Scientific Inc. 132
  • RELATED REPORTS 133
  • ?



Table 1. Snapshot of Europe Bioprocess Technology Market in Balanced Perspective, 2023-2033 17
Table 2. World Economic Outlook, 2024-2036 21
Table 3. World Economic Outlook, 2022-2024 23
Table 4. Scenarios for Economic Impact of Ukraine Crisis 27
Table 5. Scenarios for Economic Impact of Israel-Palestine War 28
Table 6. Estimated Worldwide Spending on Biopharmaceutical R&D, 2015-2023, $ billion 32
Table 7. World Health Spending by Region, $ bn, 2013-2020 33
Table 8. Main Product Trends and Market Opportunities in Europe Bioprocess Technology Market 37
Table 9. Europe Bioprocess Technology Market by Product, 2023-2033, $ mn 45
Table 10. Europe Bioprocess Technology Market: Instruments by Type, 2023-2033, $ mn 48
Table 11. Europe Bioprocess Technology Market: Consumables and Accessories by Type, 2023-2033, $ mn 55
Table 12. Europe Bioprocess Technology Market by Process, 2023-2033, $ mn 59
Table 13. Europe Bioprocess Technology Market by Procedure, 2023-2033, $ mn 63
Table 14. Europe Bioprocess Technology Market by Application, 2023-2033, $ mn 73
Table 15. Europe Bioprocess Technology Market by End User, 2023-2033, $ mn 80
Table 16. Europe Bioprocess Technology Market by Country, 2023-2033, $ mn 90
Table 17. Germany Bioprocess Technology Market by Product, 2023-2033, $ mn 92
Table 18. Germany Bioprocess Technology Market by Application, 2023-2033, $ mn 92
Table 19. Germany Bioprocess Technology Market by End User, 2023-2033, $ mn 92
Table 20. U.K. Bioprocess Technology Market by Product, 2023-2033, $ mn 94
Table 21. U.K. Bioprocess Technology Market by Application, 2023-2033, $ mn 94
Table 22. U.K. Bioprocess Technology Market by End User, 2023-2033, $ mn 94
Table 23. France Bioprocess Technology Market by Product, 2023-2033, $ mn 96
Table 24. France Bioprocess Technology Market by Application, 2023-2033, $ mn 96
Table 25. France Bioprocess Technology Market by End User, 2023-2033, $ mn 96
Table 26. Spain Bioprocess Technology Market by Product, 2023-2033, $ mn 98
Table 27. Spain Bioprocess Technology Market by Application, 2023-2033, $ mn 98
Table 28. Spain Bioprocess Technology Market by End User, 2023-2033, $ mn 98
Table 29. Italy Bioprocess Technology Market by Product, 2023-2033, $ mn 100
Table 30. Italy Bioprocess Technology Market by Application, 2023-2033, $ mn 100
Table 31. Italy Bioprocess Technology Market by End User, 2023-2033, $ mn 100
Table 32. Netherlands Bioprocess Technology Market by Product, 2023-2033, $ mn 102
Table 33. Netherlands Bioprocess Technology Market by Application, 2023-2033, $ mn 102
Table 34. Netherlands Bioprocess Technology Market by End User, 2023-2033, $ mn 102
Table 35. Bioprocess Technology Market in Rest of Europe by Country, 2023-2033, $ mn 104
Table 36. Key Vendors and Their Product Offerings 107
Table 37. Advanced Instruments LLC: Company Snapshot 110
Table 38. Advanced Instruments LLC: Business Segmentation 111
Table 39. Advanced Instruments LLC: Product Portfolio 111



Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033 16
Figure 4. Europe Bioprocess Technology Market, 2023-2033, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of Europe Bioprocess Technology Market 29
Figure 7. World Population 65 and Over, % of Total Population, 1950-2060 32
Figure 8. Primary Restraints and Impact Factors of Europe Bioprocess Technology Market 34
Figure 9. Investment Opportunity Analysis 38
Figure 10. Porter’s Fiver Forces Analysis of Europe Bioprocess Technology Market 41
Figure 11. Breakdown of Europe Bioprocess Technology Market by Product, 2023-2033, % of Revenue 46
Figure 12. Europe Addressable Market Cap in 2024-2033 by Product, Value ($ mn) and Share (%) 46
Figure 13. Europe Bioprocess Technology Market by Product: Instruments, 2023-2033, $ mn 47
Figure 14. Europe Bioprocess Technology Market by Instruments: Bioprocess Analyzers, 2023-2033, $ mn 49
Figure 15. Europe Bioprocess Technology Market by Instruments: Osmometers, 2023-2033, $ mn 50
Figure 16. Europe Bioprocess Technology Market by Instruments: Bioreactors, 2023-2033, $ mn 51
Figure 17. Europe Bioprocess Technology Market by Instruments: Incubators, 2023-2033, $ mn 52
Figure 18. Europe Bioprocess Technology Market by Instruments: Other Instruments, 2023-2033, $ mn 53
Figure 19. Europe Bioprocess Technology Market by Product: Consumables and Accessories, 2023-2033, $ mn 54
Figure 20. Europe Bioprocess Technology Market by Consumables and Accessories: Culture Media, 2023-2033, $ mn 56
Figure 21. Europe Bioprocess Technology Market by Consumables and Accessories: Reagents, 2023-2033, $ mn 57
Figure 22. Europe Bioprocess Technology Market by Consumables and Accessories: Other Consumables and Accessories, 2023-2033, $ mn 58
Figure 23. Breakdown of Europe Bioprocess Technology Market by Process, 2023-2033, % of Sales Revenue 60
Figure 24. Europe Addressable Market Cap in 2024-2033 by Process, Value ($ mn) and Share (%) 60
Figure 25. Europe Bioprocess Technology Market by Process: Upstream Bioprocessing, 2023-2033, $ mn 61
Figure 26. Europe Bioprocess Technology Market by Process: Downstream Bioprocessing, 2023-2033, $ mn 62
Figure 27. Breakdown of Europe Bioprocess Technology Market by Procedure, 2023-2033, % of Sales Revenue 64
Figure 28. Europe Addressable Market Cap in 2024-2033 by Procedure, Value ($ mn) and Share (%) 64
Figure 29. Europe Bioprocess Technology Market by Procedure: Cell Culture, 2023-2033, $ mn 65
Figure 30. Europe Bioprocess Technology Market by Procedure: Cell Expansion, 2023-2033, $ mn 66
Figure 31. Europe Bioprocess Technology Market by Procedure: Flow Cytometry, 2023-2033, $ mn 67
Figure 32. Europe Bioprocess Technology Market by Procedure: Cell Line Development, 2023-2033, $ mn 68
Figure 33. Europe Bioprocess Technology Market by Procedure: Cell Counting, 2023-2033, $ mn 69
Figure 34. Europe Bioprocess Technology Market by Procedure: Biologics Safety Testing, 2023-2033, $ mn 70
Figure 35. Europe Bioprocess Technology Market by Procedure: Tangential Flow Filtration (TFF), 2023-2033, $ mn 71
Figure 36. Europe Bioprocess Technology Market by Procedure: Other Procedures, 2023-2033, $ mn 72
Figure 37. Breakdown of Europe Bioprocess Technology Market by Application, 2023-2033, % of Revenue 74
Figure 38. Europe Addressable Market Cap in 2024-2033 by Application, Value ($ mn) and Share (%) 74
Figure 39. Europe Bioprocess Technology Market by Application: Recombinant Proteins, 2023-2033, $ mn 75
Figure 40. Europe Bioprocess Technology Market by Application: Antibiotics, 2023-2033, $ mn 76
Figure 41. Europe Bioprocess Technology Market by Application: Biosimilars, 2023-2033, $ mn 77
Figure 42. Europe Bioprocess Technology Market by Application: Monoclonal Antibodies (mAbs), 2023-2033, $ mn 78
Figure 43. Europe Bioprocess Technology Market by Application: Other Applications, 2023-2033, $ mn 79
Figure 44. Breakdown of Europe Bioprocess Technology Market by End User, 2023-2033, % of Revenue 81
Figure 45. Europe Addressable Market Cap in 2024-2033 by End User, Value ($ mn) and Share (%) 81
Figure 46. Europe Bioprocess Technology Market by End User: Biopharmaceutical Companies, 2023-2033, $ mn 82
Figure 47. Europe Bioprocess Technology Market by End User: Contract Manufacturing Organizations (CMOs), 2023-2033, $ mn 83
Figure 48. Europe Bioprocess Technology Market by End User: Academic Research Institutes, 2023-2033, $ mn 84
Figure 49. Europe Bioprocess Technology Market by End User: Contract Research Organizations (CROs), 2023-2033, $ mn 85
Figure 50. Europe Bioprocess Technology Market by End User: Food & Feed Industry, 2023-2033, $ mn 86
Figure 51. Europe Bioprocess Technology Market by End User: Other End Users, 2023-2033, $ mn 87
Figure 52. Breakdown of European Bioprocess Technology Market by Country, 2023 and 2033, % of Revenue 89
Figure 53. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 90
Figure 54. Bioprocess Technology Market in Germany, 2023-2033, $ mn 91
Figure 55. Bioprocess Technology Market in U.K., 2023-2033, $ mn 93
Figure 56. Bioprocess Technology Market in France, 2023-2033, $ mn 95
Figure 57. Bioprocess Technology Market in Spain, 2023-2033, $ mn 97
Figure 58. Bioprocess Technology Market in Italy, 2023-2033, $ mn 99
Figure 59. Bioprocess Technology Market in Netherlands, 2023-2033, $ mn 101
Figure 60. Bioprocess Technology Market in Rest of Europe, 2023-2033, $ mn 103
Figure 61. Growth Stage of Europe Bioprocess Technology Industry over the Forecast Period 105
Logo

Europe Bioprocess Technology Market Outlook, 2029

Contact usWe are friendly and approachable, give us a call.